Navigation Links
Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Date:11/9/2007

tes for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more DMARDs, such as methotrexate or TNF antagonists. ORENCIA may be used as monotherapy or concomitantly with DMARDs other than TNF antagonists. ORENCIA should not be administered concomitantly with TNF antagonists and is not recommended for use concomitantly with anakinra.

Dosing and Administration

ORENCIA is administered by a healthcare professional as a 30-minute intravenous infusion at a fixed dose based on body weight range approximating 10 mg/kg at day 0, 2 weeks, 4 weeks, and every 4 weeks thereafter. Acute infusion-related reactions were experienced in nine percent of people treated with ORENCIA and in six percent of people treated with placebo. According to the full prescribing information, the most frequently reported infusion- related adverse events (1 percent to 2 percent) were dizziness, headache, and hypertension. In pivotal studies, premedications were not required. However, appropriate medical support measures for the treatment of hypersensitivity reactions should be available for immediate use in the event of a reaction.

Important Safety Information about ORENCIA(R) (abatacept)

Before receiving treatment with ORENCIA individuals should tell their doctor if they are taking a TNF blocker (e.g., Enbrel(R), Humira(R), Remicade(R)) to treat rheumatoid arthritis (RA). ORENCIA should not be taken with these medications because of a higher chance of getting a serious infection. Individuals should also tell their doctor if they are taking Kineret(R) to treat RA. ORENCIA should not be taken with Kineret. People taking ORENCIA should notify their doctor if they are taking any other medications including hormones, over-the-counter medicines, vitamins, supplements or herbal prod
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
6. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
11. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Akcea Therapeutics, a wholly-owned subsidiary of ... today that the U.S. Food and Drug Administration ... Rx ) for the treatment of patients with ... genetic disease characterized by extremely high triglyceride levels ... study published in the NEJM in December 2014, ...
(Date:7/6/2015)... SHENZHEN, China , July 6, 2015 /PRNewswire/ -- China ... or the "Company"), a leading retail drugstore chain in ... of directly operated stores, today announced that its board ... dated July 6, 2015, from Simin Zhang , ... and China Neptunus Drugstore Holding Ltd., an investment vehicle ...
(Date:7/4/2015)... 2015 De toevoeging ... voor patiënten met niet-resectabele uitgezaaide colorectale kanker ... overleving in dat orgaan. Bij ... die alleen binnen de lever is uitgezaaid,werd ... (PFS) in de lever dankzij de toevoeging ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... November 21, 2011 Cambridge Theranostics, liquidators ... for the company,s business, which includes the intellectual property ... a dietary supplement in June 2009, Ateronon has been ... brands. The tomato pill contains an active ingredient from ...
... ROCHESTER, N.Y., Nov. 18, 2011 Phillips Lytle LLP, ... today the Appellate Division of State Supreme Court in ... fitness equipment manufacturer, Cybex International. In its ... for the accident which left Natalie Barnhard, of Cheektowaga, ...
Cached Medicine Technology:The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 2The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman 3
(Date:7/7/2015)... ... July 07, 2015 , ... ... leaders with strong managerial expertise to oversee large healthcare operations and their ... providers, business partners, insurance companies, and regulators. American Sentinel University, an innovative, ...
(Date:7/7/2015)... ... , ... On May 29, 2015, Health Canada announced that they had registered ... for gluten free oats and foods that contain them as ingredients. , “We are ... to include gluten-free oat products in Canada,” says Frank Massong, VP of Regulatory and ...
(Date:7/7/2015)... ... 2015 , ... CSG Government Solutions, a national ... Department of Vermont Health Access to provide Quality Assurance (QA) and Independent Verification ... Contact Center System project. , Vermont is implementing a strategic approach to QA/IV&V ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent stem ... are generated from adult cells, such as blood or skin, can replicate indefinitely ... body. , iPSC-derived cardiomyocytes have proven valuable in helping to ...
(Date:7/6/2015)... ... 06, 2015 , ... University of Pittsburgh Cancer Institute (UPCI) scientists ... to reflect newly available tests that better incorporate personalized medicine into diagnosing the condition. ... cancer tests is published in the July issue of the scientific journal Thyroid ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
... in Q3 2009PURCHASE, N.Y., May 12 Nutrition 21, ... marketer of nutritional supplements under the Iceland Health(R), Chromax(R) ... sugar levels, improve cardiovascular health, enhance memory and reduce ... third quarter and the first nine months of fiscal ...
... supplier, now offers DRE ASM 6000 Series multi-parameter patient monitors ... , ... (Vocus) May 12, 2009 -- DRE, Inc. ... Louisville — has expanded its diverse selection of patient monitors to ...
... Leader in Web-based admissions software for long-term care will present ... ... Atlanta, GA (PRWEB) May 12, 2009 ... for long-term care providers, announced today that it will exhibit ...
... focusing on Alzheimer,s disease, its causes, symptoms, treatment and possible ... "The Alzheimer,s Project", which includes four HBO documentaries and a ... ... Fort Lauderdale, FL (PRWEB) May 12, 2009 -- WebmasterRadio.FM, the ...
... providing thousands of discount medical supplies to thousands of home health ... department that features a wide selection of wheelchairs and scooters plus ... ... May 12, 2009 -- Providing discount medical supplies to ...
... Bethesda, MD -- Elderly Medicare beneficiaries are more satisfied ... and paying for care, than Americans with employer-sponsored insurance ... published today on the Health Affairs Web ... from the Commonwealth Fund 2007 Biennial Health Insurance Survey, ...
Cached Medicine News:Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:DRE Medical Equipment Releases New Multi-Function Patient Monitors 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 3Health News:Inside Story of HBO's Alzheimer's Project with Series Producer John Hoffman and Dr. Laurie Ryan on WebmasterRadio.FM's "Rainmaker" 2Health News:Inside Story of HBO's Alzheimer's Project with Series Producer John Hoffman and Dr. Laurie Ryan on WebmasterRadio.FM's "Rainmaker" 3Health News:Discount Medical Supplies Online Store Announces New Department Dedicated to Wheelchairs and Scooters 2Health News:Discount Medical Supplies Online Store Announces New Department Dedicated to Wheelchairs and Scooters 3Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 2Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: